Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.
Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to 32 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Systemic mastocytosis Genetic and Rare Diseases Information Center resources: Mastocytosis Systemic Mastocytosis Acute Graft Versus Host Disease Drug Information available for: Avapritinib FDA Drug and Device Resources'. This change indicates an update in the information related to genetics, rare diseases, and drug resources for the study.SummaryDifference20%
Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.